ge Y administered exogenous rCX3CL1 to mice with cerebral ischemia-reperfusion and found that rCX3CL1 could inhibit CX3CL1 signaling pathway can be used as a therapeutic target to promote functional recovery after stroke (Ge et al., 2022). The gene discussed is CX3CL1; the disease is brain ischemia.